17026-13-0 Usage
Uses
Used in Organic Synthesis:
(1E,2E)-2-Benzylidenecyclohexanone semicarbazone is used as a reagent for the determination of carbonyl compounds in organic synthesis. Its unique structure allows for the identification and quantification of carbonyl groups in various organic compounds.
Used in Pharmaceutical Industry:
(1E,2E)-2-Benzylidenecyclohexanone semicarbazone is used as a precursor in the synthesis of pharmaceutical compounds due to its ability to form metal complexes. These complexes can be used in catalytic reactions, facilitating the production of various drugs.
Used in Agrochemicals:
(1E,2E)-2-Benzylidenecyclohexanone semicarbazone is used in the development of agrochemicals, such as pesticides and herbicides. Its metal complexes can enhance the effectiveness of these chemicals, leading to improved crop protection.
Used in Materials Science:
(1E,2E)-2-Benzylidenecyclohexanone semicarbazone is used in materials science for the development of new materials with unique properties. Its metal complexes can be incorporated into various materials, such as polymers and coatings, to improve their performance and durability.
Used in Biological Research:
(1E,2E)-2-Benzylidenecyclohexanone semicarbazone is used in biological research for studying its potential anti-inflammatory and anti-cancer properties. Its ability to form metal complexes may contribute to its biological activity, making it a valuable compound for further investigation in the field of medicine.
Check Digit Verification of cas no
The CAS Registry Mumber 17026-13-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,7,0,2 and 6 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 17026-13:
(7*1)+(6*7)+(5*0)+(4*2)+(3*6)+(2*1)+(1*3)=80
80 % 10 = 0
So 17026-13-0 is a valid CAS Registry Number.
17026-13-0Relevant academic research and scientific papers
Synthesis and cytotoxic evaluation of some cyclic arylidene ketones and related oximes, oxime esters, and analogs
Dimmock,Sidhu,Chen,Li,Quail,Allen,Kao
, p. 852 - 858 (2007/10/02)
A number of arylidene derivatives of alicyclic ketones and some corresponding oximes, oxime esters, and related compounds were prepared as candidate cytotoxic agents. All of the compounds were evaluated against murine L1210 lymphoid leukemia cells. In general, cytotoxicity was greatest with the α,β-unsaturated ketones and diminished with the oximes, and the oxime esters had little or no activity in this screen. When the same compounds were examined in both the in vitro L1210 and P388 leukemia screens, in the majority of cases the L1210 cells were more sensitive to these derivatives. Over half of the compounds prepared were evaluated against approximately 55 human tumors in vitro and showed selective toxicity toward one or more groups of neoplastic diseases, particularly leukemia. Some correlations between structure and bioactivity were discerned. The cytotoxicity screening and stability studies of representative compounds suggested that the ketones, oximes, and oxime esters were stable under the conditions of bioevaluation. X-ray crystallography of four representative compounds revealed structural features associated with cytotoxicity which may be considered in the design of future candidate cytotoxins.
